ITMI
Editor’s Note: The doctor is in, and he has advice for our economic diet, The Washington Post, April 13, 2015
The chief executive of the Inova Translational Medicine Institute came to the Ritz-Carlton in Tysons Corner last week at the invitation of the Northern Virginia Technology Council. Read more in The Washingt Post, April 13, 2015.
Read MoreInova Translational Medicine Institute (ITMI) and the March of Dimes Prematurity Research Center at Stanford University School of Medicine Announce Partnership
Falls Church, VA, and Palo Alto, CA – March 9, 2015 – The Inova Translational Medicine Institute (ITMI) at Inova Fairfax Medical Campus and the March of Dimes Prematurity Research Center at Stanford University School of Medicine today announced a partnership to discover biomarkers capable of predicting risk of preterm birth using…
Read MoreDr. John Deeken Spoke with WUSA 9 about Inova’s Partnering in Clinical Research on ‘Chemo Brain’
Dr. Deeken and his colleagues at Inova Cancer Center are researching ways to help those who suffer from chemo brain. They are starting a clinical trial in collaboration with Stanford University Medical Center to understand the genetics of this chemotherapy side effect.
Read MoreInova and Personalis Announce Partnership to Advance Genomic Medicine
Falls Church, VA and Menlo Park, CA – March 27, 2014 – Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova’s patient population. Personalis will collaborate with Inova on whole genome analysis and interpretation for undiagnosed syndromes in an effort to provide patients and their families an…
Read MoreInova Translational Medicine Institute Study Featured in AP News, October 7, 2013
The Inova Translational Medicine Institute‘s 5,000-family longitudinal study to analyze genomic diseases in young children is featured in an AP News story. Watch video
Read MoreBen Solomon, MD, Geneticist joins the Inova Translational Medicine Institute
FALLS CHURCH, VA (September 30, 2013) – Ben Solomon, MD, an accomplished scientist and medical geneticist has joined the the Inova Translational Medicine Institute (ITMI). Dr. Solomon will lead a new division of Medical Genomics being formed within the ITMI. The division includes a team of genetic counselors providing direct patient care. The new division…
Read More“Inova partners with Institute for Systems Biology,” Washington Business Journal, Septebmer 25, 2013
Inova Translational Medicine Institute has signed a partnership agreement with the Institute for Systems Biology to develop tools to collect and analyze biological information now being collected by the Inova institute’s researchers for a 5,000-family longitudinal study to analyze genomic diseases in young children. Read more
Read MorePartnership Brings Power of Systems Biology to Help Integrate and Analyze Data from Large-Scale Whole Genome Sequencing Projects
FALLS CHURCH, VA and Seattle, WA, Sept. 12, 2013 – Inova Translational Medicine Institute (ITMI) has engaged the expertise of the prestigious Institute for Systems Biology (ISB) to develop bioinformatics technologies to support Inova’s large-scale whole genome sequencing projects that will bring researchers and doctors closer to the application of genomics to individual…
Read More“Ahead of its time: Inova Health targets premature births with software partnership,” Washington Business Journal, August 16, 2013
Inova’s partnership with GNS Healthcare to develop preterm birth modals that will help prioritize the testing of potential new diagnostic and treatment plans for at-risk patients is featured in, “Ahead of its time: Inova Health targets premature births with software partnership,” Washington Business Journal, August 16, 2013.
Read More“Inova, partner to develop software predicting premature births” in Washington Business Journal, August 8, 2013
The Inova Translational Medicine Institute has recently partnered with GNS Healthcare to develop preterm predictive birth models that will characterize the complex relationships between the many variables involved in order to identify the associations and underlying causal mechanisms of preterm birth and allow for personalized prediction of preterm births. Learn more in The Washington Business…
Read More